Fumarate Hydratase (FH)-Deficient Tumors
1 clinical trials · Condition
◉ Watch Fumarate Hydratase (FH)-Deficient Tumors
| Record | Firm | Date |
|---|---|---|
| Study of the Glutaminase Inhibitor CB-839 in Solid Tumors (NCT02071862) | Calithera Biosciences, Inc | 2014-02-01 |
Track Fumarate Hydratase (FH)-Deficient Tumors automatically
Every clearance here is in the API, with alerts when new ones post.